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Introduction {#sec1}
============

Traditional microbial production of valuable chemicals mainly involves constitutive or inducible expression of pathway enzymes under static control, which imposes burden and even generates suboptimal growth caused by imbalanced cofactors or toxic intermediates accumulation ([@bib16], [@bib28]). In comparison, natural cells maintain robust growth and withstand environmental fluctuations by dynamically adjusting cellular metabolism through complex regulatory networks ([@bib36]). Thus, "dynamic control" of metabolic pathway would reinforce hosts robustness and high production yield.

A synthetic dynamic control system/circuit typically consists of a biosensor and a genetic controller. Biosensor is a key component of dynamic regulatory system, which is metabolites responsive and should provide desired input-output relationships. Therefore, the tunability of the biosensor is of great importance; it must respond to a certain range of metabolites concentration with the appropriate sensitivity and threshold to ensure the precise regulation of host metabolism. The application of biosensors and genetic control circuits in metabolic engineering has been extensively reviewed ([@bib5], [@bib23], [@bib26]). So far, many biosensor-based regulatory circuits have been built, whereas a few pioneering studies ([@bib24], [@bib42], [@bib44]) can actually realize the detected dynamic regulation and can prove the existence of metabolite fluctuation. Several reports have demonstrated that tuning the biosensor performance can increase production ([@bib24], [@bib42]). However, these studies mainly focus on TF expression level, such as plasmid copy number, number of TF binding sites ([@bib39]) and promoter engineering ([@bib27]) ([@bib3], [@bib13]). Few studies reported the alteration of the sensitivity and threshold of the biosensor through the modification of the ligand-binding affinity ([@bib38]).

Heme is a critical biological macromolecule that serves as a redox active prosthetic group required for many cellular processes, such as respiration, cellular differentiation, signal transduction, circadian rhythm pathways, and gas sensing ([@bib4], [@bib8], [@bib35]). Therefore, heme is necessary for cells to maintain normal physiological functions ([@bib40]). However, excessive free heme (\>1 μM) is toxic to cells ([@bib33]). In *Escherichia coli*, the biosynthesis of heme involves the formation of 5-aminolevulinic acid (ALA) as a precursor ([@bib21]) and subsequent condensation of two ALA molecules into porphobilinogen (PBG), which finally generates heme via porphyrins ([@bib9]). The indispensability and toxicity of heme raises the difficulties in engineering the metabolic pathway related to heme biosynthesis, such as ALA, vitamin B12, siroheme, and chlorophyll. Therefore, it is essential to develop a regulatory system to enhance metabolic flux while still maintaining *in vivo* heme homeostasis.

Here, we designed and constructed a heme-responsive regulatory system to control the metabolic pathway dynamically and precisely. HrtR, a heme-sensing transporter regulator from *Lactococcus lactis* ([@bib34]), was used as the biosensor and CRISPR interference (CRISPRi) ([@bib14], [@bib31]) as a controller. This synthetic regulatory system was optimized with regard to its sensing and controlling components and was applied to pathway engineering.

Results {#sec2}
=======

Design and Characterization of a Heme-Responsive Biosensor {#sec2.1}
----------------------------------------------------------

Organism has evolved sophisticated heme regulatory system to maintain *in vivo* heme at a reasonable level via heme-sensing proteins ([@bib15]). These proteins bind heme reversibly ([@bib1]) and are usually not conserved in prokaryotic ([@bib32]) and eukaryotic cells ([@bib11], [@bib18]). HrtR acts as a heme-sensing repressor for the regulation of heme-efflux system through hrtRBA operon in *Lactococcus lactis* ([@bib34]), binds to a 15-nt special DNA sequence (*hrtO*) located in the promoter region, and controls heme homeostasis by sensing intracellular heme ([@bib22]). Therefore, HrtR and *hrtO* were selected for a heme-responsive biosensor in this study.

To evaluate the heme-responsive biosensor, the *hrtO*-hybrid trc promoter was placed upstream of *gfp* under the control of HrtR, resulting in plasmid P1. A recombinant *E. coli* strain containing different copy numbers of glutamyl-tRNA reductase gene (*hemA*) and glutamate-1-semialdehyde aminotransferase gene (*hemL*) on the genome was employed to achieve different intracellular heme accumulation ([@bib10]). Strains S1, S20, S35, S65, and S100 represented 1, 20, 35, 65, and 100 copies of *hemA*/*hemL* integrated on the genome. The above five strains were obtained through chemically inducible chromosomal evolution (CIChE) method previously in our laboratory ([@bib41]). Then plasmid P1 was transformed into recombinant *E. coli* strains. The fluorescence intensity in these strains was gradually enhanced with the increased *hemA*/*hemL* copy numbers ([Figure 1](#fig1){ref-type="fig"}A). To investigate the correlation between heme and fluorescence intensity, the intracellular heme concentration and green fluorescence intensity were also measured and analyzed. As shown in [Figure 1](#fig1){ref-type="fig"}B, the fluorescence intensity was positively correlated with intracellular heme concentration and proved that HrtR can be used as a heme-responsive biosensor.Figure 1The Evaluation the Relationship of Fluorescence Intensity and Intracellular Free Heme Concentration of the Heme Responsive Biosensor(A) The GFP expression intensity of *E. coli* strains S1P1, S20P1, S35P1, S65P1, and S100P1.(B) Linear relationship between green fluorescence intensity and intercellular heme concentration. Error bars represent ±1 SD from the mean of three replicate cultures.

Semi-Rational Design of Heme-Responsive Biosensor with Varied Binding Affinity {#sec2.2}
------------------------------------------------------------------------------

Biosensor with tailor-made ligand-binding affinity is the prerequisite for precise regulation. Heme interacts with HrtR through two histidines, His-72 and His-149, coordinates to the heme iron. The coordination between Histidines 72 and 149 with heme was supposed to form a strong affinity between HrtR and heme ([@bib34]). *In vitro* experiments showed that the addition of 1 μM heme was sufficient to fully dissociate HrtR from DNA. Based on the crystal structure of holo HrtR (PDB : [3VP5](pdb:3VP5){#intref0010}), three residues including H149 that form coordinate bond with Fe atom, V131 that locates at the entrance loop (P125-G135) of heme binding cavity, and the polar residue T68 that locates close to the nonpolar part of heme porphyrin were selected and were performed saturated mutation. The mutants were found to affect the binding affinity dramatically, which was reflected in the variation of fluorescence from 32.4% up to 280.5% of the wild-type ([Figure 2](#fig2){ref-type="fig"}, [Table S1](#mmc1){ref-type="supplementary-material"}). Among the 19 mutants at the T68 site, most had higher fluorescence intensity than the wild-type except mutant T68L. On the contrary, mutations at the V131 site caused an obvious decrease in fluorescence intensity except V131L. Remarkably, the alteration of the coordination bond had a significant effect on the fluorescence intensity. Compared with the wild-type, the H149D and H149E reduced the fluorescence intensity by approximately 67%, whereas the H149S and H149P increased the fluorescence intensity by approximately 122%. Since protein engineering at key sites of heme binding changed biosensor\'s output effectively ([Figure 3](#fig3){ref-type="fig"}B), a precise calibration of the biosensor was carried out.Figure 2The GFP Expression Intensity Heatmaps of Promoters Regulated by HrtR Saturation Mutant LibraryExperimental data are available in [Table S1](#mmc1){ref-type="supplementary-material"}.Figure 3Characterization of Heme Biosensors with Different HrtR Variations(A) The equilibrated conformations of the heme-binding regions of the wild-type and mutated HrtR (V131I, V131L, T68L, H149D, H149S) derived from molecular dynamics simulations.(B) Time-dependent GFP expression intensity under the regulation of HrtR mutants H149D, H149S, V131L, V131I, T68L.(C) Fluorescence of mutants changes after 8 h cultivation with different concentrations of heme.(D) Changes in absorbance at 413 nm after titration of mutants with heme at different concentrations. Proteins final concentration was 5 μM.(E) The Dynamic range, Sensitivity, and EC~50~ of mutants. Dynamic range is the ratio of rising fluorescence to background fluorescence, Sensitivity is the slope at EC~50~. Error bars represent ±1 SD from the mean of three replicate cultures.

To characterize the function of constructed heme-responsive biosensors, the dose-response curves of the wild-type and five chosen mutants, H149D, H149S, V131L, V131I, and T68L, were determined. Since *E. coli* K-12 strains have no natural heme uptake system, heme transporters from three different origins were selected to express in *E. coli* DH5α, such as HasA/R from *Serratia marcescens* and HutA from *Bartonella*. Only ChuA from *E. coli* O157:H7 EDL933 was effective. We established a dose-response relationship of heme and the GFP output expression of the biosensors in the ChuA-expressing strain. The fluorescence intensity was measured after cultivation for 8 h with different heme concentrations (0.01--20 μM). Since the addition of heme will affect the measurement of fluorescence, the maximum concentration added is set as 20 μM. The results are shown in [Figure 3](#fig3){ref-type="fig"}C. HrtR and its mutants H149S, T68L, and V131L showed standard dose-response curves. But 20 μM heme is not enough to support complete dissociation of mutants H149D and V131I. In addition to H149D and V131I, the dynamic range, sensitivity, and EC~50~ of the other biosensors were all calculated ([Figure 3](#fig3){ref-type="fig"}E). Compared with the wild-type, the dynamic ranges of the mutants were slightly reduced and the sensitivities of T68L and V131L to heme was significantly reduced. The EC~50~ of the different mutants in ascending order was H149S, WT, T68L, V131L.

To verify the heme responses of H149D and V131I, the *in vitro* heme affinity of HrtR and the five mutants was detected by titrating heme into apo-HrtR and measuring the change in absorbance at 413 nm ([Figure 3](#fig3){ref-type="fig"}D) ([@bib34]). When the molar ratio of heme to protein reached 1.5, H149S first reached saturation. As the ratio increased, other mutants became saturated in turn. This indicates that the heme affinity of H149D and V131I was less than that of other mutants. [Figures 3](#fig3){ref-type="fig"}D and 3E together showed that the descending order of affinity to heme is H149S, WT, T68L, V131L, V131I, H149D.

Molecular docking and molecular dynamics simulation revealed the binding affinity change of HrtR and its mutants at the molecular level. Molecular dynamics ([@bib29]) simulations demonstrated that replacing the original T68 or V131 with bulkier leucine or isoleucine residues showed marginal effect on the coordinate bonding between heme and HrtR histidines (H72 and H149) ([Figure 3](#fig3){ref-type="fig"}A). However, the binding affinity between heme and HrtR became more energetically unfavorable caused by increased steric repulsions ([Table S2](#mmc1){ref-type="supplementary-material"}). The H149D mutation led to an apparent decrease of the coordinate bond lengths ([Figure 3](#fig3){ref-type="fig"}A) and consequently a dramatic increase of steric repulsion with most unfavorable binding free energy ([Table S2](#mmc1){ref-type="supplementary-material"}). In contrast, the H149S mutation resulted in a five-coordinate heme-binding complex in which heme formed most energetically favorable binding with the H149S mutant by locating at a much more relaxed hydrophobic pocket ([Table S2](#mmc1){ref-type="supplementary-material"} and [Figure 3](#fig3){ref-type="fig"}A). The binding free energy result showed that the ligand-binding affinity of the mutants followed the order of H149S \> WT \> V131L \> T68L \> V131I \> H149D. The trend is consistent with the results of our *in vitro* and *in vivo* experiments.

Design and Construction of a Heme-Responsive Regulatory System {#sec2.3}
--------------------------------------------------------------

The heme-responsive regulatory system was designed by incorporation of heme biosensor with CRISPRi regulation. We synthesized a hybrid promoter containing the DNA-binding site (*hrtO*) of HrtR, whereas HrtR expression was driven by a constitutive promoter ([Figure 4](#fig4){ref-type="fig"}). The expression of dCas9 and sgRNA is driven by *hrtO*-hybrid promoters with the cis-regulatory *hrtO*-operator sequence located within or adjacent to the promoter. The general mechanism of the constructed system is depicted in [Figure 4](#fig4){ref-type="fig"}. In the early growth period, heme is absent/low, the constitutively expressed HrtR binds to the *hrtO*, which hinders the expression of CRISPRi. When heme is synthesized and accumulated, it interacts with HrtR and allows it dissociate from *hrtO* of *dcas9* promoter, resulting in dCas9 expression that inhibits target genes guiding by sgRNA. This further leads to the reduced heme synthesis. Again, low levels of heme results in more HrtR binding to *hrtO* and turns off CRISPRi gradually, which leads to the increased expression of target gene and the constant increase of intracellular heme. The spontaneous cycle of the system ensures the feasibility of dynamic regulation of heme biosynthesis. To increase the system turnover rate, a degradation tag AAV was added to the C terminus of the dcas9 protein.Figure 4Process of the Heme-Responsive Dynamic Regulation System: HrtR Sensed Excess Heme and Dissociated from *hrtO*, Protein dcas9 Inhibited Target Gene Expression and Reduced the Intracellular Heme ConcentrationLow level of heme results in HrtR turning off the expression of CRISPRi by recombining to *hrtO*.

Red fluorescent protein mKATE2 was used as the second marker protein to characterize the inhibition effect of CRISPRi. Similar to the design above, HrtR controlled the expression of CRISPRi and sgRNA; sgRNA was artificially designed with a complementary region to *mkate2*. Degradation tags LAA were added to the C terminus of mKATE2 to facilitate the turnover. Thus, red fluorescence intensity (i.e., the inhibitory effect of the system) can reflect the intracellular heme concentration change ([Figure 5](#fig5){ref-type="fig"}A). Five promoters with different strengths from the iGEM promoter library were selected to initiate expression of *dcas9*, and two different sgRNA targeting different positions of *mkate2* were selected to guide dcas9 ([Figure S1](#mmc1){ref-type="supplementary-material"}). Compared with strains containing sgRNA-A and control strains, the strains containing sgRNA-B located between RBS and promoter of *mkate2* showed lower red fluorescence intensity. Among them, the strain containing the promoter BBa-J23110 showed the lowest fluorescence intensity, which means that it had the best inhibition of mKATE2 ([Figure 5](#fig5){ref-type="fig"}B). So, the promoter BBa-J23110 and sgRNA-B were selected for next experiments.Figure 5Optimization of CRISPRi Action Site and Expression Intensity in Heme Regulatory System(A) Schematic representation of the dynamic regulation system represented by the reporter mKATE2.(B) Red fluorescence in strains containing different promoters of *dcas9* and different sgRNA. Error bars represent ±1 SD from the mean of three replicate cultures.

Dynamic Pathway Regulation Using the Heme-Responsive Regulation System {#sec2.4}
----------------------------------------------------------------------

To investigate the dynamic regulation pattern of this system, an sgRNA targeting the *hemB* was designed ([Figure S2](#mmc1){ref-type="supplementary-material"}). When *hemB* is inhibited, the intracellular heme concentration is reduced and CRISPRi expression is turned off, thereby canceling *hemB* inhibition. mKATE2 can be the visualization of the expression of *hemB* via the change of fluorescence. Similarly, in order to find the most suitable inhibition site for *hemB*, three various sgRNAs targeting different positions of *hemB* were used for further screening ([Figure 6](#fig6){ref-type="fig"}A). Three constructions were used as blank controls: SH0 (only contained sgRNA targeting *hemB* rather than *mkate2*); SB4 (only contained sgRNA targeting *mkate2* rather than *hemB*); SOH2 (removed off the *hrtO* site within the promoter of CRISPRi system, resulting the constitutive expression of dcas9 and sgRNA) ([Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}). The red fluorescence intensity of SH0 was the highest and that of SOH2 was the lowest. The strains in which *hemB* was inhibited had a higher fluorescence intensity than SB4 ([Figure 6](#fig6){ref-type="fig"}B). This indicated that the CRISPRi had a significant inhibitory effect on mKATE2 in normal heme accumulating *E. coli*. When *hemB* was inhibited, the intracellular heme concentration decreased, less dcas9 and sgRNA were expressed, resulting in increase in the red fluorescence intensity. This was in line with our design and proved the effectiveness of the synthetic regulatory system.Figure 6Verification of the Function of the Heme Dynamic Regulation System(A) Schematic diagram of dynamic control system acting on both *hemB* and *mkate2*.(B) Red fluorescence intensity of strains containing both sgRNA targeting *mkate2* and *hemB*. SH0 (*mkate2* is not inhibited by CRISPRi), SH1 (sgRNA-A and sgRNA-1), SH2 (sgRNA-A and sgRNA-2), SH3 (sgRNA-A and sgRNA-3), SOH2 (removed *hrtO* based on SH2, making CRISPRi constitutive expression), SB4 (only contains sgRNA-A, no sgRNA targeting *hemB*).(C) Red fluorescence intensity change after replacing the *mkate2* promoter and RBS, SH2-AL: Ptac and RBS~B0034~; SH2-AL-1: P~J23110~ and RBS~B0032~; SH2-AL-2: P~J23101~ and RBS~B0032~; SH2-AL-3: P~J23106~ and RBS~B0032~.(D) The relative expression level of dcas9 in SH2-AL changes with time.(E) The relative expression level of *hemB* in SH2-AL changes with time. Error bars represent ±1 SD from the mean of three replicate cultures.

To visualize the *in vivo* fluctuation of the gene expression, two sgRNAs simultaneously affected by *in vivo* heme concentration were designed to target *mkate2* and *hemB*, respectively. According to our design, dynamic regulation of *hemB* made the heme accumulation exhibit an oscillatory changing pattern and so does the expression of *hemB* and *mkate2*. However, results showed that the strain in which *hemB* was inhibited (SH2) had no dynamic fluctuations of red fluorescence. This may be due to the low intracellular heme concentration. To improve intracellular heme concentration, *hemA* from *Salmonella arizona* and *hemL* from *E. coli* were added to SH2 to obtain SH2-AL. No significant fluorescence fluctuations were observed again in SH2-AL. To solve this problem, we changed the promoter and RBS of mKATE2 to reduce the expression of *mkate2*. Finally, obvious fluctuations of fluorescence intensity were observed ([Figure 6](#fig6){ref-type="fig"}C). Among them, SH2-AL-2 (promoter: BBa-J23101, RBS: B0032) showed a significant fluorescence intensity change. These results indicated that the synthetic regulatory system can dynamically regulate metabolic pathway by perturbing the genes expression.

To further verify the dynamic regulation in different aspects, real-time fluorescence quantitative PCR was used to analyze the expression of *hemB* and *dcas9* at the transcriptional level. SH2-AL-2 was cultivated in a shake flask with 50 mL of LB medium and sampled for mRNA analysis every 3 h. Fluctuations were observed at different time points in the strains SH2-AL-2 ([Figures 6](#fig6){ref-type="fig"}D and 6E). The RT-PCR result proved that the synthetic regulatory system was capable of dynamically regulating dcas9 and *hemB* expression.

Increased ALA Production Using Heme-Responsive Regulatory System {#sec2.5}
----------------------------------------------------------------

Previous studies in ALA showed that direct overexpression of the key genes in heme synthesis pathway accumulated large quantity of downstream products including heme and porphyrins, which are toxic and affected cell growth ([@bib19]).

Based on SH2-AL, an ALA production strain was constructed by overexpression of *gltW* (tRNA^Glu^, the tRNA responsible for charging glutamic acid), *rhtA* (inner membrane transporter), and *gdhA* (glutamate dehydrogenase) to obtain the strain SH2-ALTG; strains SB4-ALTG (expression of *hemAL*, *gltW*, *gdhA*, *rhtA* on the basis of SB4) and SOH2-ALTG (expression of *hemAL*, *gltW*, *gdhA*, *rhtA* on the basis of SOH2) were set as control. After cultivation, strains SH2-ALTG, SB4-ALTG, SOH2-ALTG have no significant difference in cell growth and glucose consumption. SH2-ALTG accumulated 3.75g/L ALA, which was 1.54-fold of SB4-ALTG (2.42g/L) and 2.09-fold of SOH2-AL (1.8 g/L) ([Figure 7](#fig7){ref-type="fig"}A). The results showed that the dynamic regulation of *hemB* contributes to the increased ALA production.Figure 7The Application of Heme Dynamic Regulation System in ALA Production(A) Improvement of ALA production through regulation of *hemB* by heme dynamic regulation system. SOH2-ALTG: Mssing *hrtO*, constitutive expression of CRISPRi, *hemB* was continuously inhibited; SB4-ALTG: without sgRNA targeting *hemB*, *hemB* was not inhibited; SH2-ALTG: *hemB* was regulated by dynamic regulation system.(B) The ALA production of the engineered strains in which *hemB* was, respectively regulated by wild-type and five HrtR mutants. Strains ST-H149S, ST-V131L, ST-T68L, ST-V131I, and ST-H149D have amino acid mutations that occurred on the basis of SH2-ALTG.(C) Intracellular free heme concentration curve of fermentation strain. Error bars represent ±1 SD from the mean of three replicate cultures.

Mutant biosensors with different binding affinity were applied to investigate the effect of ligand-binding affinity on regulation efficiency. As expected, the binding affinity of biosensor had a significant effect on ALA production ([Figure 7](#fig7){ref-type="fig"}B). During ALA fermentation, intracellular free heme of these six strains showed a pattern of rise-decrease-rise ([Figure 7](#fig7){ref-type="fig"}B). The intracellular heme concentration of the mutant H149D was the highest. At the same time, H149D accumulates the most ALA, 5.35 g/L, which indicates that a high *in vivo* heme level at the early stage of growth is beneficial for cell growth and the ALA production.

Application of Synthetic Regulatory System in Porphyrin and Porphobilinogen Synthesis {#sec2.6}
-------------------------------------------------------------------------------------

Porphyrins play an important role in the fields of medical and materials chemistry ([@bib2], [@bib20]). First, dynamic regulation using heme-responsive biosensor was tried to synthesis PBG by designing sgRNA targeting *hemC* (encoding hydroxymethylbilane synthase). PBG accumulation of the strain under the dynamic regulation is 40.25 mg/L, 428.4% higher than that of the un-regulated strain and 80% higher than that of the constitutive-regulated strain ([Figure 8](#fig8){ref-type="fig"}B). Meanwhile, the six porphyrin compounds found in the fermentation broth were uroporphyrin (Uro), heptaporphyrin (7-CP), hexaporphyrin (6-CP), pentaporphyrin (5-CP), coproporphyrin I (CopI), and coproporphyrin III (CopIII) (among them, uroporphyrin is a mixture of uroporphyrin I and uroporphyrin III) ([Figure 8](#fig8){ref-type="fig"}A). The downstream porphyrin compounds reduced by 55.6% after dynamic regulation of *hemC*, whereas the un-regulated strains accumulated large amounts of porphyrins. Mutants (H149D, H149S, T69L) were used to investigate the regulation role of different biosensors. Among these HrtR and its mutants, wild-type HrtR was the most effective biosensor on the accumulation of PBG. The intracellular free heme of all dynamic strains showed a fluctuation trend with time. The intracellular free heme concentration of H149D was the highest within 30 h ([Figures S6](#mmc1){ref-type="supplementary-material"}B and S6D).Figure 8The Application of Heme Dynamic Regulation System in ALA Production(A) Heme biosynthesis pathway in *Escherichia coli*. *hemA*: glutamyl-tRNA reductase; *hemL*: glutamate-1-semialdehyde aminotransferase; *hemB*: 5-ALA dehydratase; *hemC*: PBG deaminase; *hemD*: uroporphyrinogen III synthase; *hemE*: uroporphyrinogen decarboxylase; *hemN*: coproporphyrinogen III oxidase; *hemY*: protoporphyrinogen oxidase; *hemH*: protoporphyrin ferrochelatase.(B) PBG and porphyrin productions in dynamic regulation *hemC* strains.(C) PBG and porphyrin productions in dynamic regulation *hemH* strains. Error bars represent ±1 SD from the mean of three replicate cultures.

We also designed sgRNA targeting *hemH* (encoding coproporphyrin ferrochelatase). The strain that dynamically regulates *hemH* (SAL-H), strain constitutively inhibiting *hemH* (SAL-HO) and SB4-AL were used for fermentation. The strain with dynamic regulatory system accumulated 65% higher porphyrin compounds than the control strains. The mutants T68L resulted in the highest porphyrin production and reached 3,263.29 μg/L ([Figure 8](#fig8){ref-type="fig"}C).

Discussion {#sec3}
==========

Biosensors with suitable sensitivity and threshold are the key for regulating the pathway dynamically and precisely. Since heme may act as an allosteric molecule that binds to regulatory proteins and regulate the heme biosynthesis, degradation, and transportation, a universal heme-responsive biosensor can be designed and constructed. Initially, two prokaryotic heme-responsive proteins were selected: iron response regulator (Irr) from *Rhizobium leguminosarum* ([@bib17]) and HrtR from *Lactococcus lactis*. However, Irr has more than two Heme Regulatory Motifs ([@bib25]) and was also affected by iron level ([@bib37]), which resulted in complexity and uncertainty. Thus, it was finally discarded after several trials.

To characterize the function of heme-responsive biosensor, a dose-response curve dependent on heme concentration should be determined. However, *E. coli* K-12 strains have no natural heme uptake system. To address this issue, we employed multi-copy integrated *hemA/hemL* strains that can provide different *in vivo* heme concentration ([@bib10]). The positive correlation between the green fluorescence intensity and the *in vivo* heme concentration was observed and guaranteed the characterization of the regulatory system ([Figure 1](#fig1){ref-type="fig"}B). And we tried to express the heme transporter HasA/R from *Serratia marcescens* and the transporter HutA from *Bartonella* in *E. coli*, but this did not work (data not shown); finally, this goal was achieved by using ChuA from *E. coli* O157:H7 EDL933. To tune the binding affinity of heme biosensor, three key sites of HrtR that were supposed to be involved in heme binding were selected for saturated mutation based on the protein structure ([@bib34]). Evaluating biosensor characteristics is necessary before its application. Based on this, a series of heme-responsive biosensors with different sensitivity and threshold were obtained. Our results proved that modifying the metabolite-binding affinity generated a very clear horizontal shift of the dose-response curve with more than 8-fold EC~50~ change and over 2-fold sensitivity change. Detailed biophysical analysis such as heme titration and molecular dynamics simulation can contribute to revealing strategies for biosensor precise control and operational direction. In a sense, some analysis like molecular dynamics simulation can be effective auxiliary methods.

The fine-tuned biosensors can be applied in many different pathways. For example, insensitive biosensor needs high heme concentration for dissociation of HrtR from the promoter regulatory site and may be suitable for heme tolerant process. When biosensor H149D was applied in ALA production, 5.35 g/L ALA was obtained. This is the highest ALA production in batch cultivation of *E. coli.*

Compared with antisense RNA (asRNA), RNA interference (RNAi), and protein degradation systems ([@bib6], [@bib30], [@bib43]), CRISPRi is a robust RNA-guided modulation system that acts at the transcriptional level other than post-transcriptional level and post-translational level. It has many advantages, such as reversibility ([@bib31]). However, it was reported that dCas9 may continuously bind to DNA and thus CRISPRi has a relatively slower turnover rate, which may affect the dynamic regulation efficiency ([@bib31]). Therefore, we designed a degradation tag to the C terminus of *dcas9* to speed up the turnover rate. The oscillatory expression of *hemB* and *dcas9* was observed after this modification ([Figures 6](#fig6){ref-type="fig"}D and 6E). The oscillation results under dynamic regulation were also verified by the results of red fluorescence and intracellular heme fluctuation ([Figures 6](#fig6){ref-type="fig"}C and [7](#fig7){ref-type="fig"}C).

Since the heme biosynthesis pathway possesses many important compounds, such as B12 ([@bib12]), siroheme, and chlorophyll ([@bib7]), and heme is a small molecule necessary for cell respiration, the heme-responsive regulatory system can be applied for many processes, including basic metabolism ([@bib45]). In a broader scientific context, biosensor with tailor-made sensitivity provides the possibility of regulating the biological process more dynamically and precisely.

Limitations of the Study {#sec3.1}
------------------------

Owing to the transport efficiency of heme transporter and the fact that excessive addition of heme will affect the fluorescence measurement, we could not determine the EC~50~ of the mutants H149D and V131I and only analyzed it by heme titration.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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